Cassaday Bryan J.

CFO Bryan J. Cassaday bought 475 shares of CTCX at $0.46 on 2024-09-10; stock down 90.4% from 52-week high, insider's prior trades at ticker show 0% 90-day win rate.

Cassaday purchased 475 shares at $0.46 on 2024-09-10, increasing holdings to 4,250 shares (+12.6%), as CTCX trades at $0.47, down 90.4% from its 52-week high of $4.87. This purchase is part of a cluster: 5 other insiders also bought within the past 14 days. However, Cassaday's historical pattern at this ticker is concerning—his prior 4 measurable trades at CTCX show a 0% 90-day win rate, with purchases resulting in -81.1%, -78.7%, -74.9%, and -33.1% declines over 90 days. The company posted a net loss of $3,304,538 in the latest quarter and remains unprofitable on a full-year basis, with minimal quarterly revenue of $12,320. The convergence of a deeply depressed stock, an insider's repeated poor timing on prior trades at the same ticker, and fundamental losses suggests this filing merits close scrutiny of the company's financial position and the motivation driving continued insider accumulation.

CFO Bryan Cassaday bought 1,000 shares of CTCX at $0.57 on 2024-08-29 amid -74.3% 90-day decline; 0 of 4 prior buys at this ticker were well-timed.

Cassaday purchased 1,000 shares at $0.57 on 2024-08-29, increasing his holdings to 3,775 shares, a +36.0% increase. The stock has since fallen to $0.64 (current price) from a 52-week high of $4.87, representing -86.9% from peak. Over the 90-day period prior to this transaction, CTCX fell -74.3%; over the preceding 30 days, it fell -39.6%. Cassaday's prior timing at CTCX has been unfavorable: his 5 previous trades at this ticker show 0 of 4 measurable buy transactions were well-timed at the 90-day mark (positive 90d returns), with the most recent buys in May and June 2024 delivering -47.8%, -48.8%, and -38.8% 90-day declines respectively. The company reported net income of $-3,304,538.00 (latest quarter) and has been unprofitable over its most recent full fiscal year. A cluster of 6 other insiders also bought within the past 14 days, though prior buy concentration did not arrest the stock's extended decline.